Concourse Financial Group Securities’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1446 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 3327 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 3321 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3368 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 3378 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 3325 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3323 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3305 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3261 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3207 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2993 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3059 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3012 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3177 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3153 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3074 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3016 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2960 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2819 |
|
|
2020
Q2 | – | Sell |
-135
| Closed | -$2K | – | 2726 |
|
|
2020
Q1 | $2K | Buy |
135
+14
| +12% | +$207 | ﹤0.01% | 1862 |
|
|
2019
Q4 | $2K | Buy |
+121
| New | +$2K | ﹤0.01% | 1870 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2426 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2807 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2784 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2655 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2205 |
|